Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Press

Showing results (191-200 of 273) with videos related to

Pageof 28
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1997
HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomasM F Press, L Bernstein, P A Thomas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2016
Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trialJ R Mackey, T Pieńkowski, J Crown, et al.
American Journal of Epidemiology|October 30, 2007
Timing of menarche and first full-term birth in relation to breast cancer riskChristopher I Li, Kathleen E Malone, Janet R Daling, et al.
Archives of Gynecology and Obstetrics|June 5, 2024
Correlation of RANK and RANKL with mammographic density in primary breast cancer patientsMarius Wunderle, Felix Heindl, Annika S Behrens, et al.
Cancers|November 11, 2022
A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix<sup>®</sup> PC1 SystemEvan N Cohen, Gitanjali Jayachandran, Richard G Moore, et al.
Research Square|June 4, 2026
A Novel Patient-Derived Xenograft Model of Inflammatory Breast CancerPrincess Ekpo, Monica Khattak, Tiffany Cheung, et al.
Breast Cancer Research : BCR|January 15, 2017
Reproductive factors and the risk of triple-negative breast cancer in white women and African-American women: a pooled analysisHuiyan Ma, Giske Ursin, Xinxin Xu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 27, 2011
Obesity and survival among black women and white women 35 to 64 years of age at diagnosis with invasive breast cancerYani Lu, Huiyan Ma, Kathleen E Malone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
HER-2 gene amplification, HER-2 and epidermal growth factor receptor mRNA and protein expression, and lapatinib efficacy in women with metastatic breast cancerMichael F Press, Richard S Finn, David Cameron, et al.
British Journal of Cancer|August 5, 2005
Reproductive factors and subtypes of breast cancer defined by hormone receptor and histologyG Ursin, L Bernstein, S J Lord, et al.
Pageof 28

Showing results (191-200 of 273) with videos related to

Sort By:
Pageof 28
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1997
HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomasM F Press, L Bernstein, P A Thomas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2016
Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trialJ R Mackey, T Pieńkowski, J Crown, et al.
American Journal of Epidemiology|October 30, 2007
Timing of menarche and first full-term birth in relation to breast cancer riskChristopher I Li, Kathleen E Malone, Janet R Daling, et al.
Archives of Gynecology and Obstetrics|June 5, 2024
Correlation of RANK and RANKL with mammographic density in primary breast cancer patientsMarius Wunderle, Felix Heindl, Annika S Behrens, et al.
Cancers|November 11, 2022
A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix<sup>®</sup> PC1 SystemEvan N Cohen, Gitanjali Jayachandran, Richard G Moore, et al.
Research Square|June 4, 2026
A Novel Patient-Derived Xenograft Model of Inflammatory Breast CancerPrincess Ekpo, Monica Khattak, Tiffany Cheung, et al.
Breast Cancer Research : BCR|January 15, 2017
Reproductive factors and the risk of triple-negative breast cancer in white women and African-American women: a pooled analysisHuiyan Ma, Giske Ursin, Xinxin Xu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 27, 2011
Obesity and survival among black women and white women 35 to 64 years of age at diagnosis with invasive breast cancerYani Lu, Huiyan Ma, Kathleen E Malone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
HER-2 gene amplification, HER-2 and epidermal growth factor receptor mRNA and protein expression, and lapatinib efficacy in women with metastatic breast cancerMichael F Press, Richard S Finn, David Cameron, et al.
British Journal of Cancer|August 5, 2005
Reproductive factors and subtypes of breast cancer defined by hormone receptor and histologyG Ursin, L Bernstein, S J Lord, et al.
Pageof 28